Article contents
“Continuous” Thioproperazine
A Controlled Trial in Chronic Schizophrenia
Published online by Cambridge University Press: 29 January 2018
Extract
Thioproperazine (‘Majeptil’) is a recently introduced phenothiazine derivative which readily produces extra-pyramidal disturbances. Its pharmacology was originally described by Courvoisier et al. (1958) and its clinical properties by a number of workers including, in this country, Denham and Carrick (1961). Several investigators have reported impressive results with this drug in a variety of mentally ill patients, including chronic schizophrenics who had failed to respond to other forms of therapy.
- Type
- Research Article
- Information
- Copyright
- Copyright © Royal College of Psychiatrists, 1963
References
- 5
- Cited by
eLetters
No eLetters have been published for this article.